ArticleFrontiers in oncology2025
CNN-TumorNet: leveraging explainability in deep learning for precise brain tumor diagnosis on MRI images.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- ChatNSG: An Overview of Contemporary and Emerging Artificial Intelligence Models for the Neurosurgeon.Journal of neurological surgery. Part B, Skull base · 2026Article
- Leveraging human-centered AI for clinical decision-making: a transparent, accurate rule extractor using non-dominated sorting genetic algorithm.BMC medical informatics and decision making · 2026Article
- BRAIN-META: A reproducible CNN-vision transformer meta-ensemble pipeline for explainable brain tumor classification.MethodsX · 2026Article
- Sustainable and interpretable heart disease prediction: a clinical decision support approach for biomedical healthcare applications.Scientific reports · 2026Article
- XMP-Net: An XAI-Based Modified Xception Model for Recognizing Monkeypox and Other Skin Diseases.BioMed research international · 2026Article
- Performance trade-offs between dense prediction and sparse query mechanisms for brain tumor MRI detection: a comparative study of YOLOv8 and RT-DETR.Frontiers in medicine · 2026Article
- Bridging modalities: a deep learning framework for brain tumor classification via CT-MRI integration and model fusion.Frontiers in computational neuroscience · 2026Article
- XcepFusion for brain tumor detection using a hybrid transfer learning framework with layer pruning and freezing.Scientific reports · 2025Article
- Clinical predictive fusion network for accurate disease prediction in patient cohorts.Scientific reports · 2025Article
- Explainable multi-view transformer framework with mutual learning for precision breast cancer pathology image classification.Frontiers in oncology · 2025Article
- Lightweight CNN for accurate brain tumor detection from MRI with limited training data.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The early identification of brain tumors is essential for optimal treatment and patient prognosis. Advancements in MRI technology have markedly enhanced tumor detection yet necessitate accurate classification for appropriate therapeutic approaches. This underscores the necessity for sophisticated diagnostic instruments that are precise and comprehensible to healthcare practitioners. Methods: Our research presents CNN-TumorNet, a convolutional neural network for categorizing MRI images into tumor and non-tumor categories. Although deep learning models exhibit great accuracy, their complexity frequently restricts clinical application due to inadequate interpretability. To address this, we employed the LIME technique, augmenting model transparency and offering explicit insights into its decision-making process. Results: CNN-TumorNet attained a 99% accuracy rate in differentiating tumors from non-tumor MRI scans, underscoring its reliability and efficacy as a diagnostic instrument. Incorporating LIME guarantees that the model's judgments are comprehensible, enhancing its clinical adoption. Discussion: Despite the efficacy of CNN-TumorNet, the overarching challenge of deep learning interpretability persists. These models may function as "black boxes," complicating doctors' ability to trust and accept them without comprehending their rationale. By integrating LIME, CNN-TumorNet achieves elevated accuracy alongside enhanced transparency, facilitating its application in clinical environments and improving patient care in neuro-oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.